UnknownNot Applicable

Acute Respiratory Distress Syndrome(ARDS) in Neonates

China200 participantsStarted 2015-08-01

Plain-language summary

Acute respiratory distress syndrome in neonates has been defined in 2015. Earlier identification and successful intervention into the potential pregnancy associated risk factors for the conversion from NRDS to ARDS is one of the most important components of ARDS prevention.

Who can participate

Age range5 Minutes – 28 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. The gestational age was less than 37 weeks;
✓. These neonates were diagnosed with NRDS; The diagnosis of NRDS was based on clinical manifestations and chest X-ray findings. The clinical signs and symptoms of NRDS were respiratory distress, tachypnea, nasal flaring, groan, and cyanosis after birth. The typical X-ray picture of RDS showed a grain shadow, air bronchogram or white lung.
✓. informed parental consent has been obtained

Exclusion criteria

✕. parents' decision not to participate;
✕. major congenital anomalies;
✕. died or left the neonatal intensive care unit(NICU) within 24 hour.

What they're measuring

the effects of Pregnancy risk factors (PRF) on the conversion from NRDS to ARDS

Timeframe: within 28 days

clarify whether PRF treatment could prevention from conversion from NRDS to ARDS

Timeframe: within 28 days

Trial details

NCT IDNCT03227289

SponsorDaping Hospital and the Research Institute of Surgery of the Third Military Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-30

Contact for this trial

Ma Juan, MD

13508300283 476679422@qq.com

View on ClinicalTrials.gov More ARDS trials